PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1999; 92(Suppl 37): 41–49.
PMCID: PMC1297023

Update on intestinal strictures.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Smyth RL, van Velzen D, Smyth AR, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994 Jan 8;343(8889):85–86. [PubMed]
  • van Velzen D. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet. 1995 Aug 19;346(8973):499–500. [PubMed]
  • Pawel BR, de Chadarévian JP, Franco ME. The pathology of fibrosing colonopathy of cystic fibrosis: a study of 12 cases and review of the literature. Hum Pathol. 1997 Apr;28(4):395–399. [PubMed]
  • Jones R, Franklin K, Spicer R, Berry J. Colonic strictures in children with cystic fibrosis on low-strength pancreatic enzymes. Lancet. 1995 Aug 19;346(8973):499–499. [PubMed]
  • Freiman JP, FitzSimmons SC. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States. J Pediatr Gastroenterol Nutr. 1996 Feb;22(2):153–156. [PubMed]
  • FitzSimmons SC, Burkhart GA, Borowitz D, Grand RJ, Hammerstrom T, Durie PR, Lloyd-Still JD, Lowenfels AB. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997 May 1;336(18):1283–1289. [PubMed]
  • Hasler WL. Pancreatic enzymes and colonic strictures with cystic fibrosis: a case-control study. Gastroenterology. 1998 Mar;114(3):609–612. [PubMed]
  • Reichard KW, Vinocur CD, Franco M, Crisci KL, Flick JA, Billmire DF, Schidlow DV, Weintraub WH. Fibrosing colonopathy in children with cystic fibrosis. J Pediatr Surg. 1997 Feb;32(2):237–242. [PubMed]
  • Stevens JC, Maguiness KM, Hollingsworth J, Heilman DK, Chong SK. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy. J Pediatr Gastroenterol Nutr. 1998 Jan;26(1):80–84. [PubMed]
  • Häusler M, Meilicke R, Biesterfeld S, Heimann G. First adult patient with fibrosing colonopathy. Am J Gastroenterol. 1998 Jul;93(7):1171–1172. [PubMed]
  • Knabe N, Zak M, Hansen A, Moesgaard J, Kvist N, Beck B, Damgaard K, Koch C. Extensive pathological changes of the colon in cystic fibrosis and high-strength pancreatic enzymes. Lancet. 1994 May 14;343(8907):1230–1230. [PubMed]
  • Pettei MJ, Leonidas JC, Levine JJ, Gorvoy JD. Pancolonic disease in cystic fibrosis and high-dose pancreatic enzyme therapy. J Pediatr. 1994 Oct;125(4):587–589. [PubMed]
  • Schwarzenberg SJ, Wielinski CL, Shamieh I, Carpenter BL, Jessurun J, Weisdorf SA, Warwick WJ, Sharp HL. Cystic fibrosis-associated colitis and fibrosing colonopathy. J Pediatr. 1995 Oct;127(4):565–570. [PubMed]
  • King SJ, Van Velzen D, Smyth RL, Carty H, Heaf D. Strictures of the colon in cystic fibrosis. Clin Radiol. 1994 Jul;49(7):476–477. [PubMed]
  • Crisci KL, Greenberg SB, Wolfson BJ, Geller E, Vinocur CD. Contrast enema findings of fibrosing colonopathy. Pediatr Radiol. 1997 Apr;27(4):315–316. [PubMed]
  • Zerin JM, Kuhn-Fulton J, White SJ, Chong SK, Stevens JC, West KW, Teitelbaum DH, Nasr SZ. Colonic strictures in children with cystic fibrosis. Radiology. 1995 Jan;194(1):223–226. [PubMed]
  • Green MR, Southern KW, Wolfe SP, Littlewood JM, Najmaldin AS, Wyatt JI. Colonic strictures in cystic fibrosis. Arch Dis Child. 1995 Feb;72(2):191–191. [PMC free article] [PubMed]
  • Waters BL. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes. Pediatr Dev Pathol. 1998 Jan-Feb;1(1):74–78. [PubMed]
  • DiMagno EP, Malagelada JR, Go VL, Moertel CG. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med. 1977 Jun 9;296(23):1318–1322. [PubMed]
  • Gow R, Bradbear R, Francis P, Shepherd R. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet. 1981 Nov 14;2(8255):1071–1074. [PubMed]
  • Beverley DW, Kelleher J, MacDonald A, Littlewood JM, Robinson T, Walters MP. Comparison of four pancreatic extracts in cystic fibrosis. Arch Dis Child. 1987 Jun;62(6):564–568. [PMC free article] [PubMed]
  • Stead RJ, Skypala I, Hodson ME, Batten JC. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Thorax. 1987 Jul;42(7):533–537. [PMC free article] [PubMed]
  • Morrison G, Morrison JM, Redmond AO, Byers CA, McCracken KJ, Dodge JA, Guilford SA, Bowden MW. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis. Aliment Pharmacol Ther. 1992 Oct;6(5):549–555. [PubMed]
  • Bowler IM, Wolfe SP, Owens HM, Sheldon TA, Littlewood JM, Walters MP. A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis. Arch Dis Child. 1993 Feb;68(2):227–230. [PMC free article] [PubMed]
  • Shah A, Dinwiddie R, Madge S, Prescott P, Hudson G. High dose Nutrizym 22 in cystic fibrosis. Eur J Pediatr. 1993 Sep;152(9):763–764. [PubMed]
  • Smyth RL, Ashby D, O'Hea U, Burrows E, Lewis P, van Velzen D, Dodge JA. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet. 1995 Nov 11;346(8985):1247–1251. [PubMed]
  • Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr. 1995 Nov;127(5):681–684. [PubMed]
  • Bakowski MT, Prescott P. Patterns of use of pancreatic enzyme supplements in fibrosing colonopathy: implications for pathogenesis. Pharmacoepidemiol Drug Saf. 1997 Sep;6(5):347–358. [PubMed]
  • Lowdon J, Goodchild MC, Ryley HC, Doull IJ. Maintenance of growth in cystic fibrosis despite reduction in pancreatic enzyme supplementation. Arch Dis Child. 1998 Apr;78(4):377–378. [PMC free article] [PubMed]
  • van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV. Comparative and experimental pathology of fibrosing colonopathy. Postgrad Med J. 1996 Mar;72 (Suppl 2):S39–S51. [PubMed]
  • Greif J, Schwarz Y, Sperber F, Jurgenson U. Benign cystic teratoma simulating organized empyema. Pediatr Pulmonol. 1997 Apr;23(4):310–313. [PubMed]
  • Dalzell AM, Freestone NS, Billington D, Heaf DP. Small intestinal permeability and orocaecal transit time in cystic fibrosis. Arch Dis Child. 1990 Jun;65(6):585–588. [PMC free article] [PubMed]
  • Seal S, McClean P, Walters M, Wolfe SP, Harding M, Coward W, Littlewood JM. Stable isotope studies of pancreatic enzyme release in vivo. Postgrad Med J. 1996 Mar;72 (Suppl 2):S37–S38. [PubMed]
  • Guarner L, Rodríguez R, Guarner F, Malagelada JR. Fate of oral enzymes in pancreatic insufficiency. Gut. 1993 May;34(5):708–712. [PMC free article] [PubMed]
  • Mac Sweeney EJ, Oades PJ, Buchdahl R, Rosenthal M, Bush A. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet. 1995 Mar 25;345(8952):752–756. [PubMed]
  • Oades PJ, Rosenthal M, Mac Sweeney EJ, Bush A. Subclinical colonic thickening. J R Soc Med. 1996;89 (Suppl 27):24–30. [PMC free article] [PubMed]
  • Ramsden WH, Moya EF, Littlewood JM. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis. Arch Dis Child. 1998 Oct;79(4):339–343. [PMC free article] [PubMed]
  • Pohl M, Krackhardt B, Posselt HG, Lembcke B. Ultrasound studies of the intestinal wall in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1997 Sep;25(3):317–320. [PubMed]
  • Haber HP, Benda N, Fitzke G, Lang A, Langenberg M, Riethmüller J, Stern M. Colonic wall thickness measured by ultrasound: striking differences in patients with cystic fibrosis versus healthy controls. Gut. 1997 Mar;40(3):406–411. [PMC free article] [PubMed]
  • Littlewood JM. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice. Postgrad Med J. 1996 Mar;72 (Suppl 2):S56–S62. [PubMed]
  • Walters MP, Kelleher J, Gilbert J, Littlewood JM. Clinical monitoring of steatorrhoea in cystic fibrosis. Arch Dis Child. 1990 Jan;65(1):99–102. [PMC free article] [PubMed]
  • Soldan W, Henker J, Sprössig C. Sensitivity and specificity of quantitative determination of pancreatic elastase 1 in feces of children. J Pediatr Gastroenterol Nutr. 1997 Jan;24(1):53–55. [PubMed]
  • Smyth RL. Fibrosing colonopathy in cystic fibrosis. Arch Dis Child. 1996 May;74(5):464–468. [PMC free article] [PubMed]
  • Croft NM, Marshall TG, Ferguson A. Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements. Lancet. 1995 Nov 11;346(8985):1265–1267. [PubMed]
  • Lee J, Ip W, Durie P. Is fibrosing colonopathy an immune mediated disease? Arch Dis Child. 1997 Jul;77(1):66–70. [PMC free article] [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press